Top Buy
Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
---|---|---|---|---|---|---|---|
Eli Lilly Corp. | 42 | 0 | 3 | 0 | 703,50 € | 751,76 € | 6,86 % |
Biogen Inc. | 42 | 0 | 3 | 0 | 201,80 € | 298,07 € | 47,71 % |
Vertex Pharmaceuticals Inc. | 36 | 2 | 2 | 0 | 378,50 € | 379,70 € | 0,32 % |
Alnylam Pharmace. | 33 | 0 | 4 | 0 | 137,20 € | 244,30 € | 78,06 % |
Regeneron Pharmaceuticals Inc. | 31 | 1 | 3 | 0 | 883,50 € | 932,90 € | 5,59 % |
Johnson & Johnson | 30 | 0 | 3 | 0 | 144,30 € | 196,36 € | 36,08 % |
Merck & Co. Inc. | 25 | 1 | 1 | 1 | 112,00 € | 124,47 € | 11,13 % |
Pfizer Inc. | 27 | 3 | 3 | 0 | 25,45 € | 40,66 € | 59,76 % |
Cytokinetics Inc. | 23 | 1 | 5 | 0 | 59,00 € | 80,35 € | 36,19 % |
Trinity Biotech ADR | 21 | 0 | 1 | 0 | 0,41 € | - | - |
Amgen Inc. | 20 | 0 | 0 | 0 | 249,00 € | 291,23 € | 16,96 % |
Neurocrine Bioscience | 19 | 0 | 2 | 0 | 128,35 € | 136,01 € | 5,97 % |
Intra-Cellular Therapies Inc. | 19 | 0 | 4 | 0 | 60,20 € | 75,68 € | 25,71 % |
Zoetis Inc. A | 19 | 0 | 1 | 0 | 157,05 € | 200,06 € | 27,38 % |
BioMarin Pharmaceutical Inc. | 18 | 0 | 2 | 0 | 77,08 € | 102,48 € | 32,95 % |
Iovance Biotherapeutics Inc. | 19 | 2 | 7 | 0 | 12,90 € | 25,20 € | 95,37 % |
EyePoint Pharmaceuticals Inc. | 16 | 0 | 0 | 0 | 19,80 € | 27,74 € | 40,11 % |
Natural Alternat. | 17 | 1 | 1 | 1 | 5,10 € | - | - |
Intellia Therapeutics Inc | 16 | 0 | 2 | 0 | 25,37 € | 60,14 € | 137,05 % |
AbbVie Inc. | 16 | 0 | 0 | 0 | 164,10 € | 172,25 € | 4,97 % |
Pacira Pharmaceuticals | 15 | 0 | 5 | 0 | 26,60 € | 52,78 € | 98,42 % |
Exelixis Inc. | 15 | 0 | 0 | 0 | 21,32 € | 26,01 € | 21,98 % |
Krystal Biotech | 15 | 0 | 4 | 0 | 155,00 € | 161,18 € | 3,98 % |
Abbott Laboratories | 16 | 1 | 0 | 0 | 103,78 € | 116,71 € | 12,46 % |
United Therapeutics | 15 | 0 | 5 | 0 | 216,50 € | 289,92 € | 33,91 % |